September 25, 2016 11:04 PM ET


Company Overview of Progen Pharmaceuticals Limited

Company Overview

As of January 29, 2016, Progen Pharmaceuticals Limited was acquired by TBG Diagnostics Limited, in a reverse merger transaction. Progen Pharmaceuticals Limited, a biotechnology company, discovers, researches, and develops pharmaceutical therapeutics for the treatment of human diseases in Australia and the United States. The company focuses on the development of the anti-angiogenesis and anti-metastatic oncology products pipeline. The company’s products in research and development stage include PG545, an anti-cancer compound in Phase Ia clinical trial; and PI-88, a heparanase inhibitor that is in Phase III clinical trial in post-resection liver cancer. It also provides contract services rela...

2806 Ipswich Road

Darra, QLD 4076



61 7 3273 9133


61 7 3375 1168

Key Executives for Progen Pharmaceuticals Limited

Progen Pharmaceuticals Limited does not have any Key Executives recorded.

Progen Pharmaceuticals Limited Key Developments

Progen Pharmaceuticals Limited will Change its Ticker to TDL from PGL

Effective February 02, 2016, Progen Pharmaceuticals Limited will change its Australian Securities Exchange stock ticker symbol to TDL from PGL.

Progen Pharmaceuticals Limited has Changed its Name to TBG Diagnostics Limited

On December 14, 2015, Progen Pharmaceuticals Limited changed its name to TBG Diagnostics Limited.

Progen Pharmaceuticals Limited Announces Changes to Board of Directors

Progen Pharmaceuticals Limited announced that Non-Executive Director, Dr. Christopher Harvey, who was due to stand for election as a Director at this year's Annual General Meeting on December 07, 2015, informed the Board that due to the overwhelming shareholder support for the new appointee directors, he decided he would not stand for election to the Board at the AGM. The Board of Directors appoints Dr. Stanley Chang, Eugene Cheng, and Emily Lee as elected directors to the Board of the company.

Similar Private Companies By Industry

Company Name Region
AbRegen Pty Ltd. Asia
Advanced Wound Care Pty Ltd. Asia
Agriliance Pty Ltd. Asia
AION Diagnostics Limited Asia
Aquaceutics Pty Ltd Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Progen Pharmaceuticals Limited, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at